Hepion Says GV104 Prevented Fentanyl-Induced Cardiac Arrest in 200-Subject Simulation
Hepion reported that its GV104 treatment prevented fentanyl-induced cardiac arrest in a simulation involving 200 subjects.
Hepion reported that its GV104 treatment prevented fentanyl-induced cardiac arrest in a simulation involving 200 subjects.